Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

GHRP-6 vs Ipamorelin

Comparison

GHRP-6 and Ipamorelin are two peptides people frequently compare. GHRP-6 is a peptide people use to boost growth hormone output for muscle recovery, body composition, and general wellness. It's also used in clinical research as a diagnostic test for GH deficiency.… Ipamorelin is a peptide people use to boost their body's own growth hormone output. It's taken for muscle recovery, body composition, better sleep, and recovery after illness or surgery. Not…

GHRP-6 Ipamorelin
What it is GHRP-6 is a peptide people use to boost growth hormone output for muscle recovery, body composition, and general wellness. It's also used in clinical research as a diagnostic test for GH deficiency.… Ipamorelin is a peptide people use to boost their body's own growth hormone output. It's taken for muscle recovery, body composition, better sleep, and recovery after illness or surgery. Not…
Primary uses
  • GH stimulation testing / diagnosis of GH deficiency in adults and children
  • GH release stimulation in healthy subjects and various clinical populations (obesity, aging, thyroid disorders, Cushing's disease/syndrome, prolactinoma, Prader-Willi syndrome, polycystic ovary syndrome, type 2 diabetes, hypothyroidism, Addison's disease)
  • Cytoprotection / organ protection in ischaemia-reperfusion and multiple organ failure
  • Acute lung injury and pulmonary fibrosis prevention/treatment
  • Growth hormone stimulation / GH-IGF-1 axis modulation
  • Postoperative ileus / gastrointestinal motility
  • Counteracting glucocorticoid-induced muscle and bone catabolism
  • Bone mineral content and longitudinal bone growth
How it works It's also used in clinical research as a diagnostic test for GH deficiency. Not FDA-approved for therapeutic use; banned by WADA; studied in organ protection and metabolic research. It's taken for muscle recovery, body composition, better sleep, and recovery after illness or surgery. Not FDA-approved; classified as investigational.
Common dose 100 mcg, subcutaneous injection, 3x daily (upon waking, pre-workout, and before bed) 200 mcg, subcutaneous injection, once daily, pre-sleep
FDA status Not stated in reviewed literature — requires manual verification Not stated in reviewed literature as FDA-approved for any indication. Reviewed literature describes ipamorelin as an unapproved/investigational compound for performance and musculoskeletal…
Evidence level Human observational Human RCT